PCV15 vaccine IM
Products billed under this code include Vaxneuvance.
Payment limit per 1 EA, by effective quarter, 1Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Vaxneuvance.
Payment limit per 1 EA, by effective quarter, 1Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Vaxneuvance | Merck | 00006-4329-02 | 1 | $269.306 |
| Vaxneuvance | Merck | 00006-4329-03 | 10 | $2,693.06 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $269.306 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted September 17, 2026 |
| 3Q26 | $269.306 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted September 15, 2026 |
| 2Q26 | $269.306 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted September 15, 2026 |
| 1Q26 | $269.306 | +$8.16 | 1 EA | PCV15 vaccine IM | v1, posted September 15, 2026 |
| 4Q25 | $261.146 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted September 8, 2026 |
| 3Q25 | $261.146 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted March 10, 2026 |
| 2Q25 | $261.146 | +$7.586 | 1 EA | PCV15 vaccine IM | v1, posted March 10, 2026 |
| 1Q25 | $253.56 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted December 19, 2025 |
| 4Q24 | $253.56 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted June 11, 2025 |
| 3Q24 | $253.56 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted June 11, 2025 |
| 2Q24 | $253.56 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted March 11, 2025 |
| 1Q24 | $253.56 | +$7.365 | 1 EA | PCV15 vaccine IM | v1, posted December 19, 2024 |
| 4Q23 | $246.195 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted October 10, 2024 |
| 3Q23 | $246.195 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted June 5, 2024 |
| 2Q23 | $246.195 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted February 23, 2024 |
| 1Q23 | $246.195 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted December 6, 2023 |
| 4Q22 | $246.195 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted June 22, 2023 |
| 3Q22 | $246.195 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted June 9, 2023 |
| 2Q22 | $246.195 | $0.00 | 1 EA | PCV15 vaccine IM | v1, posted December 14, 2022 |
| 1Q22 | $246.195 | – | 1 EA | PCV15 vaccine IM | v1, posted June 8, 2022 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.